Paul Rebattu

Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1

G. Robinet, P. Thomas, Jean-Luc Breton et al. · Annals of Oncology · 2001 · 267 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Gemcitabine–docetaxel versus cisplatin–vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin

Jean-Louis Pujol, Jean-Luc Breton, R. Gervais et al. · Annals of Oncology · 2005 · 131 citations · Full text

Medicine, Oncology, Pharmacology +16

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Xavier Pivot, Gilles Romieu, Marc Debled et al. · The Lancet · 2019 · 128 citations

Medicine, Oncology, Breast Oncology +9

Massive chemotherapy with autologous bone marrow transplantation in 50 cases of bad prognosis non‐Hodgkin's lymphoma

Thierry Philip, Pierre Biron, D Maraninchi et al. · British Journal of Haematology · 1985 · 66 citations

Medicine, Hematology, Oncology +17

Results of a European Organization for Research and Treatment of Cancer/Early Clinical Studies Group Phase II Trial of First-Line Irinotecan in Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Cervix

Catherine Lhommé, P. Fumoleau, P. Fargeot et al. · Journal of Clinical Oncology · 1999 · 60 citations

Medicine, Oncology, Pharmacotherapy +17